Faculty Profile

Jieni Li

Research Assistant Professor
Department of Pharmaceutical Health Outcomes and Policy

Office:
University of Houston College of Pharmacy
Health 2, Room 4052B
4349 Martin Luther King Boulevard
Houston, TX 77204-5047

Contact: jli87@central.uh.edu - N/A

Research:

Building real-world evidence to support clinical and policy decisions in treatment selection
Conducting observational studies on patient journeys using large-scale healthcare data
Application of machine learning in predicting treatment patterns and outcomes
Advancing personalized care through data-driven treatment strategies

Ph.D. in Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy
Master of Public Health (MPH) in Biostatistics and Epidemiology, Washington University in St. Louis George Warren Brown School of Social Work
Bachelor of Science in Chemistry, Minor in Applied Statistics, University of Illinois at Urbana-Champaign

Google Scholar Profile

Publications

Li J, Hutton GJ, Varisco TJ, Lin Y, Essien EJ, Aparasu RR. Factors associated with the initiation of high-efficacy disease-modifying agents over moderate-efficacy disease-modifying agents in multiple sclerosis. Mult Scler Relat Disord. Published online September 19, 2024. doi:10.1016/j.msard.2024.105896
Li J, Huang Y, Hutton GJ, Aparasu RR. Assessing treatment switch among patients with multiple sclerosis: A machine learning approach. Explor Res Clin Soc Pharm. 2023;11:100307. Published 2023 Jul 10. doi:10.1016/j.rcsop.2023.100307
Li J, Zakeri M, Hutton GJ, Aparasu RR. Health-related quality of life of patients with multiple sclerosis: Analysis of ten years of national data. Mult Scler Relat Disord. 2022;66:104019. doi:10.1016/j.msard.2022.104019
Li J, Chikermane SG, Earla JR, Hutton GJ, Aparasu RR. FACTORS ASSOCIATED WITH SWITCHING FROM INJECTABLE TO ORAL DISEASE MODIFYING AGENTS AMONG PATIENTS WITH MULTIPLE SCLEROSIS. Mult Scler Relat Disord. 2022;60:103703. doi:10.1016/j.msard.2022.103703
Li J, Harrison W, Cho SK. Disparity in Diabetic Eye Complications among Racial/Ethnic Minorities: An Analysis of The US Medical Expenditure Panel Survey 2009-2018. Diabetes Epidemiology and Management. 2022. doi: 10.1016/j.deman.2022.100070
Li J, Yu T, Javed I, Siddagunta C, Pakpahan R, Langston ME, Dennis LK, Kingfield DM, Moore DJ, Andriole GL, Lai HH, Colditz GA, Sutcliffe S. Does weather trigger urologic chronic pelvic pain syndrome flares? A case-crossover analysis in the multidisciplinary approach to the study of the chronic pelvic pain research network. Neurourol Urodyn. 2020;39(5):1494-1504. doi:10.1002/nau.24381
Earla JR, Li J, Hutton GJ, Bentley JP, Aparasu RR. Association of oral disease-modifying agents and their adherence trajectories with annual relapses in multiple sclerosis. Mult Scler Relat Disord. 2024;85:105539. doi:10.1016/j.msard.2024.105539
Earla JR, Li J, Hutton GJ, Johnson ML, Aparasu RR. Comparative adherence trajectories of oral disease-modifying agents in multiple sclerosis [published correction appears in Pharmacotherapy. 2023 Aug 21. doi: 10.1002/phar.2846]. Pharmacotherapy. 2023;43(6):473-484. doi:10.1002/phar.2810
Chikermane SG, Li J, Aparasu RR. Risk of Antimuscarinic Initiation with Cholinesterase Inhibitor Use in Patients with Alzheimer's Disease. Arch Gerontol Geriatr. Published online September 17, 2024. doi:10.1016/j.archger.2024.105629
Huang Y, Li J, Li M, Aparasu RR. Application of Machine Learning in Predicting Survival Outcomes Involving Real-World Data: A Scoping Review. BMC Med Res Methodol. 2023;23(1):268. Published 2023 Nov 13. doi:10.1186/s12874-023-02078-1
Huang Y, Li J, Agarwal SK. Economic and Humanistic Burden of Rheumatoid Arthritis: Results From the US National Survey Data 2018-2020. ACR Open Rheumatol. Published online August 6, 2024. doi:10.1002/acr2.11728
Javed I, Yu T, Li J, Pakpahan R, Milbrandt M, Andriole GL, Lowder JL, Lai HH, Colditz GA, Sutcliffe S. Does Pollen Trigger Urological Chronic Pelvic Pain Syndrome Flares? A Case-Crossover Analysis in the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network. J Urol. 2021;205(4):1133-1138. doi:10.1097/JU.0000000000001482
Huang Q, Borra S, Li J, Wang L, Shrestha S, Sundaram M, Janjan N. Time to Next Treatment, Health Care Resource Utilization, and Costs Associated With Ibrutinib Use Among US Veterans With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Retrospective Analysis. J Manag Care Spec Pharm. 2020;26(10):1266-1275. doi:10.18553/jmcp.2020.20095
Epperla N, Pavilack M, Olufade T, Bashyal R, Li J, Kabadi SM, Yuce H, Andritsos L. Adverse event Rates and Economic Burden Associated with Purine Nucleoside Analogs in Patients with Hairy Cell Leukemia: A US Population-Retrospective Claims Analysis. Orphanet J Rare Dis. 2020;15(1):47. Published 2020 Feb 13. doi:10.1186/s13023-020-1325-9
Cohen J, Beaubrun A, Bashyal R, Huang A, Li J, Baser O. Real-world adherence and Persistence for Newly Prescribed HIV Treatment: Single Versus Multiple Tablet Regimen Comparison among US Medicaid Beneficiaries. AIDS Res Ther. 2020;17(1):12. Published 2020 Apr 1. doi:10.1186/s12981-020-00268-1

Honors & Awards

Graduate Student Excellence Award, Department of Pharmaceutical Health Outcomes and Policy, University of Houston, 2024
Dr. Maktoob Alam Scholarship, University of Houston, 2021 - 2024
June L. Chin Presidential Endowed Fellowship, University of Houston, 2020 - 2024
Dr. Wai-ying Lam Scholarship, University of Houston, 2023
Outstanding TED Talk, Lokhandwala Lecture and Research Convocation, University of Houston, 2022
Silver Medal Poster Award, Academy of Managed Care & Specialty Pharmacy Nexus Meeting, 2020
Brown School Scholarship, Washington University in St. Louis, 2015 - 2017

Memberships

Member, International Society for Pharmacoepidemiology (ISPE), 2022 - Present
Member, American Public Health Association (APHA), 2022-Present
Member, International Professional Society for Health Economics and Outcomes Research (ISPOR), 2018 - Present
Member, Tau Sigma National Honor Society, 2013-2015